Clincosm LogoSign in Get a demo

lymphoma

Showing NaN - NaN of 125
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Lymphoma Trial in Worldwide (CX-072, ipilimumab, vemurafenib)

Completed
  • Solid Tumor
  • Lymphoma
  • Los Angeles, California
  • +30 more
Feb 7, 2022

Lymphoma Trial in Worldwide (Nivolumab)

Completed
Has Results
  • Lymphoma
  • Phoenix, Arizona
  • +44 more
Dec 13, 2021

Breast Cancer, Lymphoma Trial in United States (Atorvastatin, Placebo)

Completed
Has Results
  • Breast Cancer
  • Lymphoma
  • Los Angeles, California
  • +50 more
Dec 6, 2021

Cancer, Cancer Metastatic, Tumors Trial in Los Angeles (Elly Mobile Phone Application)

Recruiting
  • Cancer
  • +22 more
  • Elly Mobile Phone Application
  • Los Angeles, California
    Cedars Sinai Medical Center
Dec 7, 2021

Solid Tumor, Adult Trial in United States (LNS8801 -Small molecule, orally bioavailable, selective agonist of GPER,

Recruiting
  • Solid Tumor, Adult
  • Lymphoma
  • LNS8801 -Small molecule, orally bioavailable, selective agonist of GPER
  • Pembrolizumab - anti-PD-1 antibody
  • Los Angeles, California
  • +7 more
Oct 11, 2021

Lymphoma Trial in Worldwide (immunoscintigraphy, technetium Tc 99m epratuzumab)

Unknown status
  • Lymphoma
  • immunoscintigraphy
  • technetium Tc 99m epratuzumab
  • Los Angeles, California
  • +7 more
Aug 12, 2021

Lymphoma Trial in Worldwide (immunoscintigraphy, technetium Tc 99m epratuzumab)

Unknown status
  • Lymphoma
  • immunoscintigraphy
  • technetium Tc 99m epratuzumab
  • Los Angeles, California
  • +7 more
Aug 12, 2021

FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large

Completed
  • Lymphoma
  • +2 more
  • FLT-PET/CT
  • +2 more
  • Los Angeles, California
  • +3 more
May 6, 2021

Leukemia, Lymphoma, GVHD Trial in Australia, United States (cyclosporine, cyclosporine and methotrexate)

Terminated
  • Leukemia
  • +2 more
  • Los Angeles, California
  • +12 more
May 3, 2021

Lymphoma, Relapsed Lymphoma, Refractory Lymphoma Trial in United States (fimepinostat, Rituximab, venetoclax)

Completed
  • Lymphoma
  • +10 more
  • Los Angeles, California
  • +10 more
May 5, 2021

Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML) Trial in Worldwide (NiCord®

Active, not recruiting
  • Hematological Malignancies
  • +6 more
  • NiCord® (omidubicel)
  • Cord Blood Unit
  • Los Angeles, California
  • +51 more
Jan 7, 2021

Lymphoma Trial in Germany, Poland, United States (Atezolizumab [TECENTRIQ], Obinutuzumab, Polatuzumab Vedotin)

Completed
Has Results
  • Lymphoma
  • Atezolizumab [TECENTRIQ]
  • +3 more
  • Los Angeles, California
  • +18 more
Nov 30, 2020

Lymphoma Trial in United States (Tomivosertib (eFT-508))

Terminated
  • Lymphoma
  • Tomivosertib (eFT-508)
  • Los Angeles, California
  • +9 more
Oct 30, 2020

Breast Carcinoma, Cancer Survivor, Depression Trial in United States (procedure, other, behavioral)

Completed
  • Breast Carcinoma
  • +12 more
  • Management of Therapy Complications
  • +3 more
  • Los Angeles, California
  • +5 more
Oct 8, 2020

B-cell Malignancies, Colorectal Cancer (CRC), Head Neck Cancer Trial in United Kingdom, United States (Nivolumab (Phase 1),

Completed
  • B-cell Malignancies
  • +7 more
  • Nivolumab (Phase 1)
  • +4 more
  • Birmingham, Alabama
  • +23 more
Aug 26, 2020

Detecting Anal and Genital Human Papillomavirus Infection and

Completed
  • Aids-related Malignancies
  • +3 more
  • polymerase chain reaction
  • +3 more
  • La Jolla, California
  • +9 more
Aug 7, 2020

Lymphoma Trial in United States (biological, drug, genetic)

Completed
  • Lymphoma
  • rituximab
  • +7 more
  • La Jolla, California
  • +16 more
Aug 7, 2020

Blood and Tissue Samples From Aggressive Non-Hodgkin B-Cell

Completed
  • Lymphoma
  • Nonneoplastic Condition
  • polymerase chain reaction
  • laboratory biomarker analysis
  • La Jolla, California
  • +15 more
Aug 6, 2020

Lymphoma Trial in Canada, United States (rituximab)

Completed
  • Lymphoma
  • rituximab
  • Duarte, California
  • +7 more
Jul 30, 2020

Lymphoma Trial in Los Angeles (bortezomib)

Completed
Has Results
  • Lymphoma
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Jul 30, 2020

Lymphoma Trial in Los Angeles (rituximab, vinorelbine ditartrate)

Completed
  • Lymphoma
  • rituximab
  • vinorelbine ditartrate
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center, UCLA
Jul 30, 2020

Cervical Cancer, Chronic Myeloproliferative Disorders, Leukemia Trial in Los Angeles (Fragmin, )

Completed
  • Cervical Cancer
  • +8 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center, UCLA
Jul 30, 2020

Anemia, Leukemia, Lymphoma Trial in Los Angeles (darbepoetin alfa, epoetin alfa)

Completed
  • Anemia
  • +6 more
  • darbepoetin alfa
  • epoetin alfa
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center, UCLA
Jul 30, 2020

Lymphoma, Lymphoproliferative Disorder Trial in Los Angeles (bortezomib + ganciclovir)

Terminated
  • Lymphoma
  • Lymphoproliferative Disorder
  • bortezomib + ganciclovir
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Jul 29, 2020

Lymphoma Trial in Worldwide (Ibrutinib, Placebo, Rituximab)

Completed
Has Results
  • Lymphoma
  • Tucson, Arizona
  • +205 more
Mar 30, 2020